Objective-Pericytes/pericyte precursors produce milk fat globule-associated protein with epidermal growth factor and factor VIII-like domains (MFG-E8) in vivo, and this ␣ v integrin ligand enhances angiogenesis in tumors and in oxygen-induced retinopathy in mice. Inhibition of MFG-E8 production or function attenuates platelet-derived growth factor-BB (PDGF-BB)-induced migration of pericyte/pericyte precursor-like 10T1/2 cells in vitro. Herein, we describe mechanisms by which MFG-E8 modulates PDGF-BB:PDGF receptor ␤ (PDGFR␤) signaling in 10T1/2 cells.
P latelet-derived growth factor (PDGF)-BB:PDGF receptor ␤ (PDGFR␤) signaling is an important regulator of angiogenesis. PDGF-BB is released by endothelial cells (ECs), platelets, vascular smooth muscle cells (VSMCs), and inflammatory cells at sites of neoangiogenesis, and it enhances pericyte (PC) and VSMC migration and proliferation. [1] [2] [3] [4] [5] [6] PDGF-BB binding to the receptor tyrosine kinase PDGFR␤ leads to receptor dimerization, autophosphorylation, and activation of downstream signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway. Ligand-bound receptor undergoes endocytosis and can either recycle to cell surfaces or undergo ubiquitination and proteosomal or lysosomal degradation. [1] [2] [3] [7] [8] [9] Pathway activity is influenced by the quantities of receptor that are expressed, and the location of the receptor with respect to ligand and additional proteins that participate in downstream signaling.
Several receptor tyrosine kinases, including vascular endothelial growth factor (VEGF) receptor 2, PDGFR␤, epidermal growth factor receptor, and basic fibroblast growth factor receptor, are known to associate with integrins, and these associations regulate kinase activity. 10, 11 Integrin ␣ v ␤ 3 complexes with PDGFR␤ in vascular ECs, fibroblasts and cancer cells that have been treated with PDGF-BB. [12] [13] [14] Integrin ␣ v ␤ 3 -associated PDGFR␤ subsequently interacts with signaling molecules, including Src, SHP2, phospholipase C␥, phosphatidylinositol 3-kinase, and focal adhesion kinase (FAK), triggering downstream signaling. 12, [15] [16] [17] The secreted glycoprotein milk fat globule-associated protein with epidermal growth factor and factor VIII-like domains (MFG-E8) (also termed lactadherin and SED1) is composed of 2 N-terminal epidermal growth factor-like domains and 2 C-terminal discoidin-like domains (C1 and C2) that are homologous to blood coagulation factors V and VIII. 18 -22 One endothelial growth factor-like domain (E2) contains an RGD consensus integrin-binding motif, and MFG-E8 binds to integrin ␣ v ␤ 3/5 . 20, 21, 23, 24 Initial reports documented that the carboxy-terminal domains of MFG-E8 bound to negatively charged and oxidized phospholipids, 25, 26 facilitating opsonization of apoptotic cells for uptake by phagocytes. 23, 27 Interactions of MFG-E8 with ␣ v integrins have also been implicated in regulation of angiogenesis and mammary gland branching, 24, 28 whereas interactions mediated via the C1 domain are important for sperm-egg binding and enhancement of collagen turnover. 29, 30 With respect to angiogenesis, it has been reported that MFG-E8 enhanced VEGF-induced angiogenesis in an ␣ v ␤ 3 /␤ 5 integrin-dependent manner using a mouse model of acute hindlimb ischemia. 28 Our group subsequently demonstrated that MFG-E8 enhanced tumor-related angiogenesis and tumor growth in the Rip1-Tag2 mouse pancreatic tumor model, a model in which tumor progression is critically dependent on angiogenesis. 31 We have additionally characterized the involvement of MFG-E8 in the regulation of angiogenesis in tumors, and in oxygen-induced retinopathy (OIR) in mice. 32 We determined that PC/PC precursors are important sources of MFG-E8 in vivo, that MFG-E8 may enhance angiogenesis via actions on PC/PC precursors as well as ECs, and that MFG-E8 can be effectively targeted with therapeutic benefit. 32 In melanomas and in retinas of mice with OIR, MFG-E8 colocalized with PC/PC precursors rather than ECs, and PDGFR␤ϩ PC/PC precursors purified from tumors contained large amounts of MFG-E8 mRNA. Tumor-and retinopathy-associated angiogenesis was diminished in MFG-E8 knockout mice, and PC coverage of neovessels was also reduced. 32 To determine whether MFG-E8 could act directly on PDGFR␤ϩ PC/PC precursors, we studied C3H 10T1/2 cells in vitro as surrogates. 10T1/2 cells share surface markers with PCs but have multilineage differentiation potential and may be more closely related to PC precursors. Inhibition of MFG-E8 production by 10T1/2 cells using small interfering RNAs (siRNAs) and short hairpin RNAs, or inhibition of MFG-E8 action with some anti-MFG-E8 antibodies (Abs), attenuated 10T1/2 cell migration. 32 Significantly, systemic injection of Ab to MFG-E8 that inhibited 10T1/2 cell migration in vitro also resulted in inhibition of pathological neoangiogenesis in the OIR model. These results suggested that MFG-E8 derived from PC/PC precursors enhanced PDGF-BB-induced PC/PC precursor function. However, the precise mechanisms of MFG-E8 action on PC/PC precursors and mechanisms by which PDGF-BB:PDGFR␤ signaling might be regulated by MFG-E8 have not been determined.
Herein, we describe the results of experiments designed to determine whether MFG-E8 regulates PDGF-BB:PDGFR␤ signaling. We found that MFG-E8 that was produced by 10T1/2 cells associated with integrin ␣ v and PDGFR␤ on cell surfaces after PDGF-BB treatment, altered the distribution of PDGFR␤ within cells, increased the ability of PDGFR␤ to associate with FAK, and inhibited degradation of PDGFR␤, thereby enhancing PDGFR␤ signaling and cell function (migration).
Methods
Detailed descriptions of additional materials and methods used in this study are available in the supplemental materials, available online at http://atvb.ahajournals.org.
Cells and Culture Conditions
Mouse C3H-derived 10T1/2 cells (ATCC) were maintained in BME medium (Invitrogen) supplemented with 10% heat-inactivated FBS, 2 mmol/L L-glutamine, penicillin (100 U/mL), and streptomycin (100 g/mL) and were used before passage 10.
Abs
Abs and their sources were as follows: rat anti-mouse PDGFR␤ monoclonal Ab (mAb) (eBioscience), rabbit anti-mouse PDGFR␤ mAb (Millipore), rabbit anti-integrin ␣ v polyclonal Ab (pAb) (intracellular C terminus) (Millipore), rat anti-integrin ␣ v mAb (RMV-7) (Chemicon), anti-phosphotyrosine mAb (pTyr100) (Cell Signaling), anti-phospho-FAK (Tyr397) pAb (Abcam), anti-FAK pAb (Millipore), anti-phospho-Akt (Ser473) pAb (Cell Signaling), anti-Akt pAb (Cell Signaling), anti-phospho-p44/42 MAPK (extracellular signal-regulated kinase 1/2 [ERK1/2; Thr202/Tyr204]) pAb (Cell Signaling), anti-p44/42 MAPK (ERK1/2) pAb (Cell Signaling), mouse anti-ubiquitin mAb (P4D1) (Santa Cruz Biotechnology), rabbit anti-Cbl pAb (Santa Cruz Biotechnology), mouse anti-␤ actin mAb (Sigma), and rabbit anti-collagen types 1 and 4, antifibronectin, and anti-laminin pAb (Millipore). Rabbit anti-mouse MFG-E8 pAb and mouse anti-mouse MFG-E8 mAb (clones: 1H6, B10C7) were generated and characterized in our laboratory as described. 31, 32 
MFG-E8 Knockdown Experiments and Quantification of MFG-E8 mRNA
siRNA selective for mouse MFG-E8 mRNA were designed using the Qiagen GeneGlobe Search Center (MFG-E8 siRNA) (5Ј-AAGCGGTGGAGACAAGGAGTT-3Ј), and MFG-E8 siRNA and AllStars negative control siRNA were purchased from Qiagen. To inhibit MFG-E8 production, 10T1/2 cells (5ϫ10 5 cells per 60-mm plate) were transfected with 10 nmol/L siRNA using HiPerFect Transfection Reagent (Qiagen). After 48 hours, MFG-E8 mRNA levels were assessed by quantitative reverse transcription-polymerase chain reaction (RT-PCR). Total RNA was isolated with RNeasy Kits (Qiagen) and reverse transcribed using the Super-ScriptIII First-Strand Synthesis System for RT-PCR (Invitrogen). Quantitative RT-PCR was performed using the following primers: MFG-E8 (forward, 5Ј-ATCTACTGCCTCTGCCCTGA-3Ј; reverse, 5Ј-ACACAGACGAGGCGGAAATC-3Ј) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (forward, 5Ј-ACCCAGAAGACTGTGGATGG-3Ј; reverse, 5Ј-CACATTG-GGGGTAGGAACAC-3Ј). PCR products were generated and then quantified using SYBR Green PCR Master Mix (Applied Biosystems) and a CFX96 Real-Time PCR Detection System (Bio-Rad) equipped with CFX Manager software, version 1.5.
Assessment of PDGF-Related Signaling Activities via Immunoprecipitation and Immunoblotting
Relationships between MFG-E8 levels, and PDGFR␤ expression and PDGF-BB-related signaling were probed using MFG-E8 siRNA. In these experiments, 10T1/2 cells were transfected with siRNA oligonucleotides (MFG-E8 siRNA or control siRNA), shifted to lowserum (0.5% FCS) medium after 24 hours, and then stimulated with PDGF-BB (50 ng/mL) for 0 to 120 minutes after an additional 24 hours (48 hours after transfection). After washing with ice-cold PBS, cells were disrupted in lysis buffer (20 mmol/L Tris-HCl [pH 7.6], 140 mmol/L NaCl, 1% Nonidet P-40) containing a protease inhibitor cocktail (Roche) and phosphatase inhibitor (Roche) (complete lysis buffer) on ice. Cell lysates were centrifuged at 10 000g for 15 minutes at 4°C, and the resulting supernatants were subjected to immunoprecipitation using rat anti-PDGFR␤ mAb or rat IgG as a control or to SDS-PAGE followed by immunoblot analysis with rabbit anti-PDGFR␤ mAb, anti-phosphotyrosine mAb (pTyr100), and anti-ubiquitin mAb (P4D1) as indicated. Supernatants were also subjected to SDS-PAGE, followed by immunoblot analysis using anti-phospho-FAK (Tyr397) pAb, anti-FAK pAb, anti-phospho-Akt (Ser473) pAb, anti-Akt pAb, anti-phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) pAb, anti-44/42 MAPK (Erk1/2) pAb, and anti-␤ actin mAb. Anti-mouse or anti-rabbit horseradish peroxidase-conjugated secondary Abs (Jackson Laboratory) were used in conjunc-tion with ECL (Pierce) for immunoblotting. Densitometric analysis of exposed films was accomplished using ImageJ software.
To examine the effect of the MEK/ERK kinase inhibitor PD98059 on PDGF-BB-induced phosphorylation of ERK1/2 and FAK and degradation of PDGFR␤, 10T1/2 cells were preincubated with 50 mol/L PD98059 (Sigma) or the same amount of dimethyl sulfoxide (0.2%, vehicle control) for 30 minutes and then stimulated with PDGF-BB (50 ng/mL) for 30 minutes. Cells were then disrupted in lysis buffer and subjected to SDS-PAGE, followed by immunoblot analysis as described above.
The ability of MFG-E8 to regulate PDGFR␤ expression and cell signaling was also assessed using anti-MFG-E8 Abs. In these experiments, 10T1/2 cells were preincubated for 20 minutes with anti-MFG-E8 mAb (B10C7), a rabbit anti-MFG-E8 pAb reactive with the N terminus (including the RGD-containing domain), or corresponding control Abs (all at 20 g/mL) and then stimulated with PDGF-BB (50 ng/mL) for 0 to 30 minutes. Cells were then disrupted in lysis buffer and subjected to SDS-PAGE, followed by immunoblot analysis as described above.
Signaling Complex Characterization via Coimmunoprecipitation
10T1/2 cells were incubated with 0.5% FCS medium overnight. On the day of the experiment, cells were pretreated with 100 ng/mL recombinant MFG-E8 for 15 minutes and then incubated with PDGF-BB (50 ng/mL) (PeproTech) for 0 to 30 minutes. After being washed with ice-cold PBS, cells were disrupted on ice in complete lysis buffer, lysates were cleared via centrifugation at 10 000g for 15 minutes at 4°C, and supernatants were incubated for 3 hours at 4°C with Ab-coated protein G-Sepharose beads (Amersham Biosciences). Rat anti-PDGFR␤ mAb (eBioscience) or rabbit anti-␣ v integrin pAb (C terminus, Intracellular, Millipore) were added as appropriate, and rat IgG or rabbit IgG were used as relevant controls. Beads were then washed 3 times with 1-mL volumes of wash buffer (50 mmol/L HEPES-NaOH [pH 7.6], 150 mmol/L NaCl, 0.1% Triton X-100), suspended in SDS sample buffer, boiled, and subjected to SDS-PAGE followed by immunoblot analysis using the indicated Abs and an ECL detection system (Amersham Bioscience).
Immunofluorescence Microscopy and Image Analysis
To assess colocalization/association of PDGFR␤ and MFG-E8, and effects of MFG-E8 on PDGFR␤ expression by 10T1/2 cells, cells were stained with anti-PDGFR␤ and anti-MFG-E8 after treatment with control siRNA and MFG-E8 siRNA. To accomplish this, 10T1/2 cells were transfected with control siRNA or MFG-E8 siRNA oligonucleotides, seeded in 8-well culture slides (BD Falcon) 24 hours after transfection and incubated with 0.5% FCS medium for an additional 24 hours. Forty-eight hours after siRNA treatment, cells were treated with PDGF-BB (50 ng/mL) for 0 to 120 minutes, and then fixed in 4% paraformaldehyde (PFA) in PBS at room temperature for 30 minutes. After being blocked with 3% dry milk-PBS (Bio-Rad) supplemented with 5% normal goat serum for 1 hour at room temperature, cells were stained with rabbit anti-MFG-E8 pAb and rat anti-PDGFR␤ Ab followed by Alexa 488 -or Alexa 568 -conjugated secondary Ab and Alexa 647-phalloidin (Invitrogen). Cells were mounted in ProLong Gold antifade reagent (Invitrogen), and immunofluorescence images were collected and visualized with a LSM510 confocal laser-scanning microscope (Zeiss). Quantification of PDGFR␤, MFG-E8, and phosphotyrosine expression levels per cell and extents of colocalization were accomplished with Zeiss AIM (v4.2) software. Each data point represents analysis of 10 randomly chosen cells. Cell borders were determined by visualizing stress fibers with phalloidin as necessary.
Visualization of protein-associated intracellular phosphotyrosine in 10T1/2 cells was achieved via treatment with 0.1% Triton X-100 at room temperature for 30 minutes after fixation with 4% PFA, followed by staining with anti-phosphotyrosine mAb (PY100) and anti-PDGFR␤ mAb. To compare images of permeabilized and nonpermeabilized cells, cells were fixed in 4% PFA with or without subsequent 0.1% Triton X-100 treatment before staining with Abs (see Supplemental Figure II ). These results strongly support the conclusion that immunofluorescence staining of fixed cells that have not been permeabilized with detergent results in preferential detection of proteins that are extracellular or are located on external cell surfaces.
MFG-E8-Related Proteins and Assessment of Cell Binding
MFG-E8-Ig is a fusion protein that is comprised of the N-terminal 148 amino acids of MFG-E8, including the endothelial growth factor-like domains (E1 and E2) and the linker region (L) fused in frame with the hinge-containing Fc region of human IgG1 ( Figure  1B) . RGE-MFG-E8-Ig is the corresponding point mutant of MFG-E8-Ig in which aspartic acid (D) in the RGD motif was replaced by glutamic acid (E). cDNA fragments encoding MFG-E8-Ig, and RGE-MFG-E8-Ig were subcloned into pCl-neo vector (Promega), and 293F cells (Invitrogen) were transfected with these plasmids. Fusion proteins produced by 293F cells grown in serum-free medium were purified from culture supernatants via affinity chromatography using protein A-Sepharose 4 Fast Flow (GE Healthcare Biosciences) with acid elution followed by rapid neutralization. All fusion proteins migrated as homogenous dimers in size exclusion columns under nondenaturing conditions, in contrast to recombinant MFG-E8, which formed aggregates of various sizes (data not shown).
To test fusion protein binding, 10T1/2 cells were seeded into 8-well culture slides (BD Falcon) and incubated with 0.5% FCS medium overnight. Cells were subsequently treated with MFG-E8-Ig or RGE-MFG-E8-Ig (20 g/mL) for 20 minutes and then incubated with PDGF-BB (50 ng/mL) for 0 to 60 minutes, followed by fixation with 4% PFA in PBS. After being blocked with 3% dry milk-PBS (Bio-Rad) supplemented with 5% normal goat serum for 1 hour at room temperature, cells were stained with anti-PDGFR␤ Ab followed by Alexa 488 -conjugated anti-rat Ig, Alexa 568 -conjugated anti-human Ig and Alexa 647-phalloidin (Invitrogen), washed and mounted in ProLong Gold before visualization.
To assess effects of anti-integrin ␣ v blocking Ab on binding of MFG-E8-Ig to 10T1/2 cells, 10T1/2 cells were incubated with rat anti-integrin ␣ v blocking mAb (RMV-7) (Chemicon) or control rat Ig (20 g/mL) for 20 minutes and then treated with MFG-E8-Ig (20 g/mL) for 20 minutes. After MFG-E8-Ig treatment, cells were incubated with PDGF-BB (50 ng/mL) for 0 or 5 minutes. Cells were subsequently washed, fixed in 4% PFA in PBS, and stained with Alexa 568 -conjugated anti-human Ig and Alexa 647-phalloidin (Invitrogen), and immunofluorescence images were collected and analyzed.
Statistics
Probability values were calculated using the Student t test (2-sided) or by analysis of 1-way ANOVA followed by the Bonferroni post test as appropriate. Error bars represent standard errors of the mean, and numbers of experiments (n) are as indicated.
Results

MFG-E8 Enhances PDGF-BB-Induced Phosphorylation of ERK1/2 and FAK
We previously determined that 10T1/2 cells express PC markers, including PDGFR␤; that they produce MFG-E8; and that inhibition of MFG-E8 production using siRNA inhibited PDGF-BB-dependent 10T1/2 cell migration but not proliferation. 32 Because PDGF-BB-induced ERK1/2 and FAK activation downstream of PDGFR␤ phosphorylation has been reported to be important for VSMC migration, we hypothesized that MFG-E8 might modulate this pathway. 1, 15, 16, 33, 34 We examined the effect of MFG-E8 on PDGFR␤-stimulated signaling in 10T1/2 cells by assessing phosphorylation of MAPK, FAK, and Akt in MFG-E8 siRNA and control siRNA-transfected cells. MFG-E8 mRNA expression in MFG-E8 siRNA-transfected cells was inhibited by Ϸ75% relative to that in control siRNA-transfected cells (Figure 2A ). We confirmed that the protein level of MFG-E8 was similarly inhibited by MFG-E8 siRNA using immunoblot and ELISA assays (Figure 2A ).
In immunoblots of whole cell lysates, MFG-E8 depletion using siRNA significantly reduced phosphorylation of ERK1/2 as early as 2 minutes after PDGF-BB stimulation ( Figure 2B ). Phosphorylated FAK was also significantly decreased by depletion of MFG-E8 from 10T1/2 cells, but this became evident at later time points ( Figure 2B ). In contrast, PDGF-dependent Akt phosphorylation was not influenced by modulation of MFG-E8 production, suggesting that MFG-E8 selectively enhances PDGF-BB-induced phosphorylation of ERK1/2 and FAK, consistent with our previous functional data regarding selective effects of MFG-E8 on 10T1/2 cell migration ( Figure 2C ). 32 We also examined the effect of the MEK/ERK kinase inhibitor PD98059 34 on the enhancement of PDGF-BB-induced phosphorylation of ERK1/2 and FAK and migration by MFG-E8. As previously demonstrated, 32 inhibition of MFG-E8 production using siRNA inhibited PDGF-BB-dependent 10T1/2 cell migration ( Figure 2C ). The MEK/ERK kinase inhibitor PD98059 effec-tively inhibited PDGF-BB-induced control and MFG-E8 siRNA-transfected cell migration. As expected, inhibition of PDGF-BB-induced phosphorylation of ERK1/2 in control and MFG-E8 siRNA-transfected cells by PD98059 was almost complete ( Figure 2D ). In contrast, the MEK/ERK kinase inhibitor had no effect on PDGF-BB-induced phosphorylation of FAK in control and MFG-E8 siRNAtransfected cells. These results suggest that potentiation of MFG-E8-induced activation of ERK1/2 contributes to the enhancement of PDGF-BB-induced migration and that ERK1/2 activation is downstream of MFG-E8-enhanced FAK phosphorylation.
MFG-E8 Enhances PDGF-BB-Induced Phosphorylation of PDGFR␤ and Inhibits PDGF-BB-Dependent PDGFR␤ Degradation
PDGF-BB-induced PDGFR␤ autophosphorylation is required for activation of downstream signaling pathways. In initial anti-phosphotyrosine immunoblots of whole cell lysates, PDGF-BB-induced phosphorylation of a 190-kDa protein, consistent with PDGFR␤ based on molecular size ( Figure 2B , top panel). Phosphorylation of this protein was significantly attenuated in MFG-E8-depleted cells. To confirm that the 190-kDa protein represented PDGFR␤, we performed immunoprecipitation/immunoblotting experiments with anti-PDGFR␤ and anti-phosphotyrosine Ab. We confirmed that phosphorylation of PDGFR␤ was increased after PDGF-BB stimulation, peaking at Ϸ5 minutes after stimulation and gradually decreasing to basal levels by 60 minutes (Figure 3A, top panel) . In MFG-E8-depleted 10T1/2 cells, PDGF-BB-dependent PDGFR␤ phosphorylation was decreased relative to controls. Differences between control and MFG-E8 siRNA-treated cells were evident from 5 to 30 minutes after PDGF-BB stimulation and continued up to 120 minutes after stimulation ( Figure 3A, top panel) . FAK is required for both integrin-and growth factor-stimulated cell migration. 15, 16, 33 It has been reported that FAK associates with activated PDGFR␤ through its N-terminal domain and with integrins through its C-terminal domain, thereby promoting PDGF-BB-stimulated cell migration. 15, 16 We also detected PDGFR␤-associated FAK in PDGFR␤ immunoprecipitates by immunoblotting with anti-FAK Ab ( Figure 3A , bottom panel). Interestingly, PDGF-BB-augmented association of FAK with PDGFR␤ was strikingly dependent on MFG-E8 ( Figure 3A, bottom panel) .
The amount of total PDGFR␤ that was immunoprecipitated from control 10T1/2 cells increased 2 to 10 minutes after PDGF-BB treatment, and decreased by 30 minutes after Figure 3A, middle panel) . Total PDGFR␤ expression in MFG-E8 siRNA-transfected cells was significantly decreased relative to that in control cells from 10 to 60 minutes after PDGF-BB stimulation, suggesting that MFG-E8 might inhibit PDGF-BB-dependent PDGFR␤ degradation. Addition of recombinant MFG-E8 to MFG-E8 siRNA-transfected cells reversed the decreases in FAK-PDGFR␤ association, and PDGFR␤ phosphorylation and levels of PDGFR␤ were increased to some extent (Supplemental Figure I) . To additionally address the issues of PDGFR␤ expression and distribution, we examined effects of MFG-E8 on PDGFR␤ and phosphotyrosine levels and assessed colocalization of phosphotyrosine and PDGFR␤ in situ via confocal laser immunofluorescence microscopy (Figure 3B) . Consistent with the immunoblotting results, PDGFR␤ levels were somewhat decreased, and phosphotyrosine levels were dramatically decreased, in MFG-E8 siRNA-transfected cells compared with controls. Colocalization of phosphotyrosine and PDGFR␤ (presumably phosphorylated-PDGFR␤) was also decreased in MFG-E8 siRNA-transfected cells, consistent with our association studies. In aggregate, these results suggest that MFG-E8 inhibits PDGF-BB-dependent PDGFR␤ degradation and enhances both phosphorylation of PDGFR␤ and association of FAK with activated PDGFR␤.
We previously determined that PDGF-BB-induced 10T1/2 cell migration was inhibited by rabbit anti-MFG-E8 pAb, which recognized the N terminus of MFG-E8, as well as mouse anti-MFG-E8 mAb B10C7, which recognized the RGD motif in the E2 domain, and that injection of these Abs also inhibited angiogenesis in OIR in mice. 32 Consistent with results that we obtained with MFG-E8 siRNA, both anti-MFG-E8 neutralizing Abs inhibited PDGF-BB-induced phosphorylation of PDGFR␤ and led to decreased receptor levels in PDGF-BB-stimulated cells ( Figure 3C ). These results are consistent with the concept that at least some MFG-E8 that is secreted by 10T1/2 cells acts extracellularly to potentiate PDGFR␤ phosphorylation, to attenuate decreases in PDGFR␤ levels that occur in PDGF-BB stimulated cells, and thereby to enhance PDGF-BB-mediated signaling in 10T1/2 cells.
MFG-E8 Associates With PDGFR␤ in PDGF-BB-Stimulated Cells
MFG-E8 has been reported to bind to integrin ␣ v ␤ 3/5 via its RGD motif. 20, 21, 23, 24 It has also been reported that integrin ␣ v ␤ 3 associates with phosphorylated PDGFR␤ in NIH3T3 cells treated with PDGF-BB, and this association enhances downstream signaling. 12, 13 We therefore hypothesized that PDGF-BB induces association of MFG-E8, integrin ␣ v , and PDGFR␤, providing a possible link between MFG-E8 formation and PDGFR␤-mediated signaling. To test this, we characterized PDGF-BB-induced physical interactions between MFG-E8 and PDGFR␤ via coimmunoprecipitation. Serum-starved 10T1/2 cells were stimulated with PDGF-BB, lysed, and immunoprecipitated with anti-PDGFR␤ mAb. MFG-E8 was detected in PDGFR␤ immunoprecipitates; the association of PDGFR␤ and MFG-E8 was increased 5 minutes after PDGF-BB stimulation and decreased by 30 minutes after stimulation ( Figure 4A, top panels) .
To examine relationships between MFG-E8 and PDGFR␤ in situ, we assessed colocalization of these proteins on the surfaces of 10T1/2 cells. To test the feasibility of our approach, we performed PDGFR␤ and phosphotyrosine immunofluorescence staining in both permeabilized (0.1% Triton X-treated) and nonpermeabilized (Triton X-nontreated) PFA-fixed 10T1/2 cells (see Supplemental Figure II ). Thirty minutes after PDGF-BB stimulation, PDGFR␤ staining of nonpermeabilized cells was significantly reduced compared with that of permeabilized cells and also compared with that of nonpermeabilized unstimulated cells. In contrast, phosphotyrosine staining in permeabilized cells was significantly increased after PDGF-BB stimulation and was minimal in nonpermeabilized cells in the presence or absence of PDGF-BB treatment. We interpret these findings to indicate that in the absence of detergent treatment, immunofluorescence staining of PFA-fixed cells detects primarily external surface-associated proteins.
Having established that our experimental approach could be informative, we examined PDGF-BB-induced association of MFG-E8 with PDGFR␤ on the surfaces of PDGF-BBtreated nonpermeabilized 10T1/2 cells via immunofluorescence confocal laser microscopy ( Figure 4B) , and quantified the colocalization of MFG-E8 and PDGFR␤, as well as levels of expression of MFG-E8 and PDGFR␤ on the surfaces of 10T1/2 cells ( Figure 4C ). Before treatment with PDGF-BB, PDGFR␤ was diffusely distributed on 10T1/2 cells, and some MFG-E8 was also present on cell surfaces ( Figure 4B and 4C ; MFG-E8). After treatment with PDGF-BB, PDGFR␤ staining became punctate and then decreased dramatically (Ϸ30% by 2 minutes after stimulation and diminishing to Ϸ40% of initial levels at the end of the 120-minute observation period; Figure 4B and 4C; PDGFR␤). In contrast, surface-associated MFG-E8 increased Ϸ50% by 2 minutes after PDGF-BB Figure 3 . (Continued) the indicated times, lysed, and then immunoprecipitated (IP) with rat anti-PDGFR␤ antibody (Ab) followed by immunoblotting (IB) with anti-phosphotyrosine (pTyr100), anti-PDGFR␤, and anti-focal adhesion kinase (FAK) Ab. Phosphorylated PDGFR␤, total PDGFR␤, and PDGFR␤-associated FAK expression was quantified as described. The amount of phosphorylated PDGFR␤ in control siRNA-transfected cells at 2 minutes after PDGF-BB stimulation was assigned a value of 1. The amount of PDGFR␤ and FAK in control siRNA-transfected cells at 0 minutes after PDGF-BB stimulation was assigned a value of 1. (*PϽ0.05 relative to siRNA control; values determined in 3 independent experiments). B, Digital fluorescence images depicting phosphorylated-tyrosine (red) and PDGFR␤ (green) in control siRNA-or MFG-E8 siRNA-transfected 10T1/2 cells after incubation with PDGF-BB for the indicated times (scale barϭ20 m). Colocalization of phosphotyrosine and PDGFR␤ was assessed using a Zeiss LSM510 confocal microscope and Zeiss AIM software. C, 10T1/2 cells were incubated with anti-MFG-E8 monoclonal Ab (mAb) (B10C7), rabbit anti-MFG-E8 polyclonal Ab (pAb), or corresponding control Abs (20 g/mL), and then stimulated with PDGF-BB for the indicated times. Cells were disrupted in lysis buffer, and then subjected to SDS-PAGE, followed by immunoblotting. The amount of phosphorylated PDGFR␤ in control Ig treated cells at 5 minutes after PDGF-BB stimulation was assigned a value of 1. The amount of PDGFR␤ in control Ig treated cells at 0 minutes after PDGF-BB stimulation was assigned a value of 1. Figure 4 . Platelet-derived growth factor (PDGF)-BB induces association of milk fat globule-associated protein with epidermal growth factor and factor VIII-like domains (MFG-E8) with PDGF receptor (PDGFR) ␤ on cell surfaces. A, PDGF-BB enhances association of MFG-E8 and PDGFR␤. Serum-starved 10T1/2 cells were stimulated with PDGF-BB and subjected to immunoprecipitation (IP) with rat stimulation and continued to increase, reaching levels 2.5 times higher than those on unstimulated cells by 30 minutes after PDGF-BB addition ( Figure 4C ). At least some of this increase may be attributable to increased MFG-E8 production, because MFG-E8 mRNA levels in 10T1/2 cells were increased within 5 minutes after PDGF-BB was added (Supplemental Figure III) .
Interestingly, colocalization of PDGFR␤ and MFG-E8 increased after PDGF-BB treatment, and this colocalization persisted for 120 minutes after stimulation ( Figure 4B and 4C; colocalization of PDGFR␤ and MFG-E8 on cell surfaces). The fraction of PDGFR␤ that colocalized with MFG-E8 increased after PDGF-BB stimulation; Ϸ5% of PDGFR␤ colocalized with MFG-E8 before stimulation, increasing to Ϸ30% colocalization 120 minutes after stimulation ( Figure 4C ; fraction of PDGFR␤ that colocalized with MFG-E8). To determine whether MFG-E8 might modulate PDGFR␤ surface levels or distribution, we studied siRNAtreated, MFG-E8-depleted and control siRNA-transfected 10T1/2 cells ( Figure 4B and 4C) . Surface PDGFR␤ expression by control siRNA-treated cells decreased in a timedependent manner at a slower rate than was observed with MFG-E8 siRNA treated cells ( Figure 4C ; PDGFR␤). Differences were evident beginning 5 minutes after PDGF-BB treatment and persisted for up to 120 minutes. These results suggest that 10T1/2 cell-derived MFG-E8 potentiates receptor clustering and that physical association of MFG-E8 with PDGFR␤ may lead to retention of PDGFR␤ at cell surfaces with concordantly augmented signaling.
Interactions of MFG-E8 and PDGFR␤ Are Mediated by ␣ v Integrins
We predicted that association of MFG-E8 with PDGFR␤ was dependent on integrin ␣ v and the RGD motif present in the second endothelial growth factor-like domain of MFG-E8. To test this, we immunoprecipitated integrin ␣ v from untreated and PDGF-BB-treated 10T1/2 cells and assayed for copurifying MFG-E8 and phosphoproteins of interest by immunoblotting with anti-MFG-E8 and anti-phosphotyrosine, respectively. Association of integrin ␣ v and MFG-E8 was observed before stimulation and was slightly increased at 5 minutes after stimulation ( Figure 1A, top panels) . Anti-phosphotyrosine immunoblots revealed a 190-kDa tyrosine-phosphorylated protein, consistent with phosphorylated PDGFR␤, that associated with ␣ v integrin after PDGF-BB stimulation ( Figure 1A , middle panels, lane 3). These results indicate that MFG-E8 binds integrin ␣ v before PDGF-BB stimulation and that PDGFR␤ is recruited into relevant complexes only after PDGF-BB-stimulated receptor autophosphorylation.
To confirm that MFG-E8 binds to cell-associated integrin ␣ v via the RGD consensus integrin-binding motif in the E2 domain of MFG-E8, we compared the binding of several MFG-E8 fusion proteins to the surfaces of 10T1/2 cells. MFG-E8-Ig is a fusion protein composed of the N terminus of MFG-E8 (without the C1 and C2 domains) fused in frame to the Fc portion of human IgG1, and RGE-MFG-E8-Ig represents the corresponding RGE point mutant ( Figure 1B) . These proteins, rather than recombinant MFG-E8, were used because they can easily be distinguished from residual MFG-E8 that is produced by 10T1/2 cells. In addition, these fusion proteins exist in solution as homogenous dimers as compared with the multiple aggregated species that are present in preparations of recombinant full length MFG-E8, making experimental results potentially easier to interpret. Immunofluorescence staining showed that MFG-E8-Ig bound to the surfaces of 10T1/2 cells with or without PDGF-BB treatment ( Figure 1C : PDGFR␤ in green, MFG-E8related proteins in red). After stimulation with PDGF-BB, MFG-E8-Ig colocalized in punctate clusters with PDGFR␤. In contrast, we could not detect RGE-MFG-E8-Ig binding to 10T1/2 cells ( Figure 1C ). Binding of MFG-E8-Ig to 10T1/2 cells was also readily inhibited by anti-integrin ␣ v blocking Ab ( Figure 1D ). These results indicate that MFG-E8 binds to ␣ v integrins and that integrin-MFG-E8 binding is RGD dependent, and they suggest that PDGF-BB-induced interactions of MFG-E8 with PDGFR␤ are dependent on ␣ v -containing integrins.
MFG-E8 Inhibits PDGF-BB-Dependent Ubiquitination of PDGFR␤
Levels of PDGFR␤ and activity of the PDGF-BB:PDGFR␤ signaling axis can be regulated by receptor ubiquitination, and polyubiquitination triggers receptor degradation. [7] [8] [9] To determine whether MFG-E8 depletion of 10T1/2 cells led to increased PDGFR␤ ubiquitination, we assayed immunoprecipitated PDGFR␤ for associated ubiquitin and polyubiquitin via immunoblotting with anti-ubiquitin Ab. We found that PDGF-BB-induced ubiquitination of PDGFR␤ was significantly higher in MFG-E8 siRNA-transfected cells than in control siRNA-transfected cells ( Figure 5A , top panel). Quantification of total amounts of PDGFR␤ and ubiquitinated PDGFR␤ 10 minutes after PDGF-BB stimulation revealed that PDGFR␤ levels in MFG-E8-depleted cells were Ϸ40% lower than in control cells (as expected), whereas the proportion of PDGFR␤ that was ubiquitinated in MFG-E8depleted cells was increased by Ϸ60% compared with that in control cells ( Figure 5B ). c-Cbl is a ubiquitin E3 ligase that has been implicated as a negative regulator of PDGFR␤, and PDGFR␤ is a substrate for c-Cbl. [35] [36] [37] [38] We determined that the association of c-Cbl with PDGFR␤ was increased in MFG-E8 siRNA-transfected cells ( Figure 5A, middle panel) . In addition, we demonstrated that the proteasome inhibitor MG132 inhibited PDGF-BB-induced PDGFR␤ degradation in control and MFG-E8 siRNA-transfected cells (Supplemental Figure  IV) . These results suggest that MFG-E8 reduces the association of c-Cbl with PDGFR␤, PDGFR␤ ubiquitination, and receptor degradation via the proteasomal pathway, thereby enhancing cell surface PDGFR␤ levels and PDGFR␤mediated signaling. The MEK/ERK kinase inhibitor PD98059 had no effect on PDGFR␤ degradation ( Figure 2D , bottom panel), indicating that ERK activity did not influence regulation of PDGFR␤ degradation by MFG-E8.
Discussion
MFG-E8 enhances VEGF-induced angiogenesis in a mouse model of acute hindlimb ischemia, 28 tumor-associated angiogenesis in pancreatic ␤-cell tumors in Rip1-Tag2 mice 31 and melanomas, 32 and angiogenesis in a mouse OIR model as well. 32 In a previous study, we demonstrated that PC/PC precursors as well as ECs are relevant sources of angiogenesis-promoting MFG-E8 and determined that PDGF-BB-induced migration of PC/PC precursor 10T1/2 cells was inhibited by MFG-E8 depletion using siRNA and by anti-MFG-E8 neutralizing Abs ( Figure 2C) . 32 In the present study, we sought to characterize the mechanism(s) by which MFG-E8 regulates PDGF-BB-induced alterations in cellular physiology, focusing on alterations downstream of PDGFR␤ activation.
Depletion of MFG-E8 from 10T1/2 cells using siRNA led to decreased PDGFR␤ and ERK1/2 phosphorylation after PDGF-BB stimulation, and FAK Y397 phosphorylation became transient. These effects were selective in that Akt phosphorylation was not significantly altered. PDGF-BBinduced ERK1/2 activation is known to be required for smooth muscle cell motility. 15 Phosphorylation of FAK at Y397 promotes recruitment of SH2 domain-containing adaptor proteins, including Src, phosphatidylinositol 3-kinase, and Shc, and subsequently leads to ERK activation that is important for integrin-stimulated cell migration, including PDGF-BB-induced migration. 15, 16, 33 Laser scanning confocal microscopy confirmed a global attenuation of PDGF-BBstimulated tyrosine phosphorylation in MFG-E8-depleted cells and suggested that whole cell PDGFR␤ levels also decreased more rapidly after stimulation in MFG-E8-depleted cells. Coimmunoprecipitation studies indicated that PDGFR␤ entered into complexes with MFG-E8 after receptor ligation, presumably via interactions that are mediated by ␣ v integrin that binds to FAK. This provides a possible link between MFG-E8 production and PDGF-BB:PDGFR␤ signaling. Confocal microscopy confirmed colocalization of cell surface-associated MFG-E8 and PDGFR␤ that increased over time after PDGF-BB addition, and it demonstrated higher levels of PDGFR␤ on surfaces of MFG-E8-producing cells as compared with MFG-E8-depleted cells. Interestingly, ubiquitination of PDGFR␤ was also enhanced in MFG-E8depleted cells. Associations between the E3 ubquitin ligase c-Cbl and PDGFR␤ also increased in MFG-E8-depleted 10T1/2 cells, and inhibition of the proteasome prevented ligand-induced PDGFR␤ degradation. Finally, we formally demonstrated that MFG-E8-related proteins interact with 10T1/2 cells via the RGD consensus integrin-binding sequence in the E2 domain of MFG-E8 and ␣ v -containing integrins.
PDGF-BB:PDGFR␤ binding leads to receptor dimerization, receptor autophosphorylation, recruitment of requisite signaling molecules into supramolecular complexes, and receptor internalization. [1] [2] [3] Although receptor internalization is likely to ultimately lead to decreased signaling overall, receptors and associated proteins in endosomal compartments may continue to signal. Some internalized receptors may recycle to cell surfaces where they are available to continue to participate in signaling events, whereas others are degraded in proteasomes and lysosomes. Persistent ubiquitination of PDGFR␤ has been reported to target this protein for destruction via the proteasome-and lysosome-dependent pathways. [7] [8] [9] Thus, the activity of the PDGF-BB:PDGFR␤ signaling axis can be regulated via multiple mechanisms. Levels of expression of growth factor, receptor, downstream kinases, phosphatases, and scaffolding proteins are all relevant, but the physical and temporal locations of these components in relationship to one another are also critical.
Several recent studies have focused on regulation of PDGFR␤ ubiquitination as an important mechanism by which PDGF-BB:PDGFR␤ signaling can be modulated. The E3 ligase c-Cbl is thought to be primarily responsible for PDGFR␤ ubiquitination, and regulation of c-Cbl expression and activity influences PDGF-BB:PDGFR␤ signaling. [35] [36] [37] [38] Low-density lipoprotein receptor-related protein 1 binds to c-Cbl, preventing c-Cbl:PDGFR␤ interaction and PDGFR␤ ubiquitination. In the absence of lipoprotein receptor-related protein 1, ubiquitination and degradation of PDGFR␤ is enhanced and PDGF-BB:PDGFR␤ signaling is attenuated. 39 Endothelin and smooth muscle-derived neuropilin-like protein regulates PDGF-BB:PDGFR␤ signaling via a different mechanism. Knockdown of endothelin and smooth musclederived neuropilin-like protein in VSMCs using siRNA causes coordinate increases in PDGFR␤ signaling, proliferation, and migration that are accompanied by diminished PDGFR␤ ubiquitination and turnover, as well as decreased c-Cbl mRNA and protein expression. 40 In the present study, we demonstrate the existence of another route by which PDGFR␤ ubiquitination may be regulated and PDGF-BB:PDGFR␤ signaling can be augmented. 10T1/2 cells secrete MFG-E8 under basal conditions, and MFG-E8 production (as assessed at the mRNA level) was rapidly increased after PDGF-BB treatment. On the basis of its tendency to aggregate in solution and its predominately extracellular location in tissues 29 and because it has previously been reported to bind to collagen, 30 we believe that secreted MFG-E8 is readily incorporated into extracellular matrix. Indeed, we detected laminin, fibronectin, and collagen type 1 that was deposited in close proximity to 10T1/2 cells that were propagated in vitro (Supplemental Figure V) . Matrix-associated MFG-E8 binds to ␣ v -containing integrins, and these proteins become incorporated into cell surfaceassociated supramolecular complexes that include phosphorylated FAK and PDGFR␤ (and other proteins) in the presence of growth factor. Binding of MFG-E8 to ␣ v -containing integrins promotes retention of PDGFR␤ at cell surfaces, reduces receptor ubiquitination by preventing PDGFR␤ from becoming accessible to c-Cbl, and potentiates PDGF-BBmediated signaling that involves FAK Y397 phosphorylation and subsequent activation of downstream signaling molecules, including ERK1/2, resulting in increased PDGFR␤dependent cellular responses including cell migration.
The scenario that we propose above provides a framework in which to consider the activities of MFG-E8 more globally. Although we have made a strong case for PCs as significant sources of MFG-E8 in situ, other cells (including ECs, VSMCs, macrophages and tumor cells) also have the capacity to produce the protein. 20, 22, 28, 31 We have determined that MFG-E8 preferentially regulates PDGF-BB-stimulated migration of PC/PC precursor 10T1/2 cells, whereas others have demonstrated that MFG-E8 augments VEGF-induced EC proliferation and survival. 28 Thus, in the setting of reparative angiogenesis, MFG-E8 can be produced by, and act on, several types of cells by potentiating the stimulatory effects of several growth factors. Recent experience with so-called molecular targeting small molecules indicates that drugs that have inhibitory effects on multiple targets (kinases) may be more efficacious than those that are more specific. It is tempting to speculate that, by analogy, inhibition of MFG-E8 production or action may be more advantageous than inhibition of a single signaling pathway, stimulated by VEGF, for example. It will also be interesting to determine whether the mechanisms by which MFG-E8 enhances VEGF signaling are distinct from those that we have described as operative for PDGF-BB.
